GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Patient Information Leaflet last updated on the eMC: 03/11/2009
PIL Zofran Suppositories

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to dosage and administration
Updated on 24/08/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 31/10/2006 and displayed until 24/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 22/05/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 20/12/2004 and displayed until 22/05/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 04/07/2003 and displayed until 20/12/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 02/07/2003 and displayed until 04/07/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 07/12/2000 and displayed until 02/07/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ondansetron


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk